Cargando…

Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma

PURPOSE: Anaplastic thyroid carcinoma (ATC) uniformly present with aggressive disease, but the mutational landscape of tumors varies. We aimed to determine whether tumor mutations affect survival outcomes in ATC. MATERIALS AND METHODS: Patients who underwent mutation sequencing using targeted gene p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jennifer Rui, Montierth, Matthew, Xu, Li, Goswami, Maitrayee, Zhao, Xiao, Cote, Gilbert, Wang, Wenyi, Iyer, Priyanka, Dadu, Ramona, Busaidy, Naifa L., Lai, Stephen Y., Gross, Neil D., Ferrarotto, Renata, Lu, Charles, Gunn, Gary Brandon, Williams, Michelle D., Routbort, Mark, Zafereo, Mark E., Cabanillas, Maria E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530586/ https://www.ncbi.nlm.nih.gov/pubmed/35977347 http://dx.doi.org/10.1200/PO.21.00504

Ejemplares similares

Recent advances and emerging therapies in anaplastic thyroid carcinoma
por: Cabanillas, Maria E., et al.
Publicado: (2018)

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
por: Iyer, Priyanka C., et al.
Publicado: (2018)

OR27-6 Combination Vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL1 Inhibitor) in BRAF-V600E Mutated Anaplastic Thyroid Cancer (ATC): Initial Safety and Feasibility
por: Cabanillas, Maria, et al.
Publicado: (2019)

Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma
por: Iyer, Priyanka C., et al.
Publicado: (2018)

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma
por: Wang, Jennifer R., et al.
Publicado: (2019)

PSAT385 Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer
por: Vodopivec, Danica M, et al.
Publicado: (2022)

Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF(V600E) Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study
por: Zhao, Xiao, et al.
Publicado: (2023)

Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
por: Hamidi, Sarah, et al.
Publicado: (2023)

Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics
por: Lu, Lina, et al.
Publicado: (2023)

Neoadjuvant selpercatinib for advanced medullary thyroid cancer
por: Jozaghi, Yelda, et al.
Publicado: (2020)

Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion–Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?
por: Waguespack, Steven G., et al.
Publicado: (2022)

Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
por: Busaidy, Naifa Lamki, et al.
Publicado: (2012)

MON-491 TRK-Fusion Thyroid Cancer: A Clinical Overview in a Large Population at a Single Cancer Center
por: Fazeli, Sasan, et al.
Publicado: (2020)

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns
por: Nguyen, Ha, et al.
Publicado: (2021)

MON-554 Brain Metastases in Thyroid Cancer: Molecular Profile and Institutional Experience of a Single Tertiary Referral Center in the Era of Kinase Inhibitor Therapy
por: Agosto Salgado, Sarimar, et al.
Publicado: (2019)

Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer
por: Cabanillas, Maria E., et al.
Publicado: (2011)

MON-LB015 Sporadic MTC in Children: Characterization of a Rare Disease
por: Gammons, Sarah, et al.
Publicado: (2020)

Anaplastic Thyroid Carcinoma with Gastric Metastasis
por: CHAVEZ, A.A.L., et al.
Publicado: (2018)

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
por: Fullmer, Tanner, et al.
Publicado: (2021)

RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
por: Bagheri-Yarmand, Rozita, et al.
Publicado: (2021)

MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier
por: Waguespack, Steven, et al.
Publicado: (2019)

SAT630 Analytical Validation Of A Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay
por: Iyer, Priyanka, et al.
Publicado: (2023)

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
por: Datar, Saumil, et al.
Publicado: (2020)

Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis
por: Vander Poorten, Vincent, et al.
Publicado: (2022)

Bilateral spontaneous pneumothoraces in anaplastic thyroid cancer
por: Kazzaz, Farah I., et al.
Publicado: (2019)

Unusual presentation of endocarditis with nutritional variant Streptococci
por: DADU, RAZVAN T., et al.
Publicado: (2013)

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors()()
por: Treger, Taryn D., et al.
Publicado: (2018)

Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
por: Hegde, Aparna, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center
por: Jeun, Rebecca, et al.
Publicado: (2021)

Anaplastic Lymphoma Kinase Immunocytochemistry in Fine Needle Aspiration Diagnosis of Anaplastic Large-cell Lymphoma
por: Ramteke, Prashant, et al.
Publicado: (2018)

TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
por: Ok, Chi Young, et al.
Publicado: (2015)

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
por: Subbiah, V., et al.
Publicado: (2021)

Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid
por: Shojaie, Danielle, et al.
Publicado: (2021)

Parapharyngeal Dissection for Papillary Thyroid Cancer
por: Tran, Justin, et al.
Publicado: (2019)

Lateral Neck Dissection for Papillary Thyroid Cancer
por: Tran, Justin, et al.
Publicado: (2020)

Somatic Mosaicism of IDH1 R132H Predisposes to Anaplastic Astrocytoma: A Case of Two Siblings
por: Lee, Sulgi, et al.
Publicado: (2020)

An ensemble approach to accurately detect somatic mutations using SomaticSeq
por: Fang, Li Tai, et al.
Publicado: (2015)

Response of differentiated but not anaplastic teratoma to interferon.
por: Rustin, G. J., et al.
Publicado: (1984)

The genetic landscape of anaplastic astrocytoma
por: Killela, Patrick J., et al.
Publicado: (2013)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
por: Turner, Suzanne D.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5js7g3liu8ghcj96pbhl309d81